Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 103Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1STRIDES ACROLAB

02 1STRIDES ARCOLAB LTD

03 2STRIDES PHARMA

04 5AUROBINDO PHARMA

05 2AUROBINDO PHARMA LTD

06 5BRISTOL MYERS SQUIBB

07 3CHARTWELL RX

08 3CIPLA

09 5CIPLA LIMITED

10 1EMCURE PHARMA

11 1GILEAD SCIENCES

12 1HETERO DRUGS LTD

13 1HETERO LABS LTD III

14 1HETERO LABS LTD V

15 3LAURUS

16 4MACLEODS PHARMS LTD

17 1MATRIX LABS

18 4MATRIX LABS LTD

19 3MICRO LABS LTD

20 3MICRO LABS LTD INDIA

21 3MYLAN

22 2MYLAN LABS LTD

23 1PAR FORMULATIONS PRIVATE LTD

24 1PHARMACARE LTD

25 2TEVA PHARMS USA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

RLD :

TE Code :

STAVUDINE; LAMIVUDINE; EFAVIRENZ

Brand Name : STAVUDINE; LAMIVUDINE; EFAVIRENZ

Dosage Form : TABLET; ORAL

Dosage Strength : 40MG; 150MG; 600MG

Approval Date :

Application Number : 22097

RX/OTC/DISCN :

RLD :

TE Code :

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

RLD :

TE Code :

EFAVIRENZ

Brand Name : EFAVIRENZ 200MG SCORED TABLETS

Dosage Form : TABLET; ORAL

Dosage Strength : 200MG

Approval Date :

Application Number : 22420

RX/OTC/DISCN :

RLD :

TE Code :

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

RLD : No

TE Code :

EFAVIRENZ

Brand Name : EFAVIRENZ

Dosage Form : TABLET;ORAL

Dosage Strength : 600MG

Approval Date : 2021-06-16

Application Number : 78509

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

Strides Pharma Science

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

RLD : No

TE Code : AB

EFAVIRENZ

Brand Name : EFAVIRENZ

Dosage Form : TABLET;ORAL

Dosage Strength : 600MG

Approval Date : 2018-03-12

Application Number : 204869

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Strides Pharma Science

05

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

EFAVIRENZ

Brand Name : SUSTIVA

Dosage Form : CAPSULE;ORAL

Dosage Strength : 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1998-09-17

Application Number : 20972

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

06

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

EFAVIRENZ

Brand Name : SUSTIVA

Dosage Form : CAPSULE;ORAL

Dosage Strength : 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1998-09-17

Application Number : 20972

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

07

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

EFAVIRENZ

Brand Name : SUSTIVA

Dosage Form : CAPSULE;ORAL

Dosage Strength : 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1998-09-17

Application Number : 20972

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

08

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

EFAVIRENZ

Brand Name : SUSTIVA

Dosage Form : TABLET;ORAL

Dosage Strength : 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2002-02-01

Application Number : 21360

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

09

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

EFAVIRENZ

Brand Name : SUSTIVA

Dosage Form : TABLET;ORAL

Dosage Strength : 600MG

Approval Date : 2002-02-01

Application Number : 21360

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

10

IMCAS Asia
Not Confirmed
arrow
arrow
IMCAS Asia
Not Confirmed

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Brand Name : ATRIPLA

Dosage Form : TABLET;ORAL

Dosage Strength : 600MG;200MG;300MG

Approval Date : 2006-07-12

Application Number : 21937

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank